HECHI CHEMICAL(000953)2023-04-19 16:00Financial Performance - The company's operating revenue for 2022 was ¥160,612,375.12, a decrease of 1.02% compared to ¥162,273,039.66 in 2021[23]. - The net profit attributable to shareholders was -¥100,436,899.14, representing a decline of 1,102.53% from a profit of ¥10,018,330.39 in the previous year[23]. - The net cash flow from operating activities was ¥799,521.87, down 88.09% from ¥6,710,748.57 in 2021[23]. - The basic earnings per share were -¥0.27, a decrease of 1,000.00% compared to ¥0.03 in 2021[23]. - Total assets at the end of 2022 were ¥286,706,539.83, a reduction of 27.67% from ¥396,411,315.40 at the end of 2021[23]. - The net assets attributable to shareholders decreased by 56.13% to ¥77,839,963.09 from ¥177,419,002.38 in 2021[23]. - The company reported a significant decline in both net profit and cash flow, indicating potential challenges in sustaining operations[23]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the audit report[23]. Revenue Breakdown - The company's total revenue for Q1 2022 was approximately ¥40.97 million, while Q2 revenue increased to ¥52.94 million, followed by a decline to ¥37.98 million in Q3 and further down to ¥28.72 million in Q4[28]. - The net profit attributable to shareholders was negative in all quarters, with Q1 at -¥1.43 million, Q2 at ¥3.07 million, Q3 at -¥5.73 million, and Q4 at -¥96.34 million[28]. - The net cash flow from operating activities showed a positive trend in Q1 and Q2 at ¥3.25 million and ¥9.14 million respectively, but turned negative in Q3 and Q4, recording -¥8.86 million and -¥2.74 million[28]. - The company's revenue from the pharmaceutical intermediates segment was CNY 50,256,563.62, a decrease of 43.97% year-on-year, with a gross margin of 20.84%[52]. - The fertilizer business generated revenue of CNY 109,535,068.83, an increase of 60.39% year-on-year, with a gross margin of 1.27%[52]. - Domestic sales accounted for 86.96% of total revenue, amounting to CNY 139,672,115.12, reflecting a 24.15% increase year-on-year[52]. Research and Development - The company plans to increase investment in R&D and market expansion to diversify its product offerings and explore new fields, particularly in CDMA projects[35]. - The company has maintained a strong focus on R&D, with a dedicated team working on new product development and process optimization[44]. - Research and development expenses decreased by 44.45% to CNY 4,279,280.23 due to a reduction in R&D projects[60]. - The company plans to develop new processes for the synthesis of dezocine intermediates, aiming for industrial production to expand its product range[61]. - The company invested a total of ¥34,365,988.23 in the construction of a multifunctional pilot workshop, achieving 100% completion but with no realized revenue yet[75]. Corporate Governance - The company held three shareholder meetings during the reporting period, ensuring equal rights for all shareholders, especially minority shareholders[92]. - The company has established an independent financial department with a complete financial accounting system, ensuring no interference from the controlling shareholder in financial activities[96]. - The company has established a sound corporate governance structure, continuously improving its governance level in compliance with relevant laws and regulations[94]. - The board of directors actively participated in meetings, with no director raising objections to company matters during the reporting period[120]. - The company has implemented strict insider information management to prevent any leakage of sensitive information during reporting periods[95]. Environmental Responsibility - The company holds a valid Pollutant Discharge Permit, effective from April 10, 2021, to April 9, 2026[137]. - The company has achieved zero exceedance in pollutant emissions throughout the year, as confirmed by self-monitoring reports[141]. - The company has been rated as an environmentally friendly enterprise by the Chongqing Ecological Environment Bureau during the reporting period[144]. - The company has invested approximately CNY 390,000 in optimizing and upgrading its waste gas treatment facilities and wastewater treatment station during the reporting period[143]. - The company has implemented a two-level spray adsorption + low-temperature plasma + activated carbon adsorption process for its waste gas treatment facilities[143]. Shareholder Information - The company has a total of 30,776 shareholders at the end of the reporting period, with significant shareholders including Ningbo Yinyi Holdings with 23.76% and Guangxi Hechi Chemical Industry Group with 10.24%[192]. - The company reported that 87,000,000 shares held by Ningbo Yinyi Holdings are pledged, and 37,493,589 shares held by Guangxi Hechi Chemical Industry Group are frozen[192]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 241.03 million[117]. - The company has not proposed any cash dividend distribution during the reporting period, despite having a positive profit available for distribution to shareholders[129]. - The company has not reported any risks during the supervisory activities of the board of supervisors in the reporting period[125]. Strategic Initiatives - The company plans to enhance R&D investment to develop new products and improve profitability, aiming to accelerate the trial production of the multifunctional pilot workshop project[85]. - The company aims to maintain its market share in existing products while expanding into new customer segments and optimizing product structure[84]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of CNY 500 million allocated for potential mergers and acquisitions[110]. - The management emphasized a commitment to sustainability, aiming for a 25% reduction in carbon emissions by 2025[110]. - The company plans to enhance its digital marketing strategy, expecting a 30% increase in online sales channels by the end of 2023[110].